Results 11 to 20 of about 74,551 (265)
The field of cancer nanomedicine seeks to overcome the inherent shortcomings of conventional cancer diagnostics and therapies. Yet despite the surge of interest in and attractive attributes of nanotechnologies, challenges remain in their clinical translation, prompting some to argue that they have not yet reached their true potential. In this Viewpoint
Sangeeta N Bhatia +2 more
exaly +3 more sources
Heterojunction Nanomedicine [PDF]
AbstractExogenous stimulation catalytic therapy has received enormous attention as it holds great promise to address global medical issues. However, the therapeutic effect of catalytic therapy is seriously restricted by the fast charge recombination and the limited utilization of exogenous stimulation by catalysts.
Chao Pan +5 more
openaire +3 more sources
Many diseases originate from alterations in biologic processes at the molecular or nanoscale level. Mutated genes, misfolded proteins, and infections caused by viruses or bacteria can lead to cell malfunction or miscommunication, sometimes leading to life-threatening diseases.
Kim, Betty Y. S. +2 more
openaire +3 more sources
Nanoproteomics for Nanomedicine [PDF]
677 ISSN 1743-5889 Nanomedicine (2010) 5(5), 677–682 10.2217/NNM.10.46 © 2010 Future Medicine Ltd “Label-free NAPPA technology, in combination with protein nanobiocrystallography and its possible future development using anodic porous alumina along with a cell-free expression system ...
NICOLINI, CLAUDIO, PESHKOVA, EVGENIYA
openaire +3 more sources
Personalized Nanomedicine [PDF]
Abstract Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines—that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents ...
Lammers, T. +3 more
openaire +4 more sources
Magnetic Nanoparticles for Therapy and Diagnosis in Nanomedicine [PDF]
Magnetic nanoparticles (MNPs) have been widely used for their potential applications, mainly for the diagnosis and/or therapy (theranostic) of several diseases in the field of nanomedicine, as passive contrast agents, through the opsonization process, or
Gamarra , Lionel Fernel +7 more
core +1 more source
Since the launch of the Alliance for Nanotechnology in Cancer by the National Cancer Institute in late 2004, several similar initiatives have been promoted all over the globe with the intention of advancing the diagnosis, treatment and prevention of cancer in the wake of nanoscience and nanotechnology.
Paolo Decuzzi +19 more
openaire +6 more sources
This Special Issue on Cancer Nanomedicine within Cancers brings together 46 cutting-edge papers covering research within the field along with insightful reviews and opinions reflecting our community [...]
openaire +5 more sources
As the science and technology of nanomedicine speed ahead, ethics, policy and the law are struggling to keep up. It is important to proactively address the ethical, social and regulatory aspects of nanomedicine in order to minimize its adverse impacts on the environment and public health and also to avoid a public backlash.
David B, Resnik, Sally S, Tinkle
openaire +2 more sources

